Published in
Elsevier, Journal of Hepatology, 5(67), p. 999-1008
DOI: 10.1016/j.jhep.2017.06.026
Links
Tools
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Journal article published in 2017 by
Jordi Bruix 
,
Ann-Lii Cheng,
Gerold Meinhardt,
Keiko Nakajima,
Yoriko De Sanctis,
Josep Llovet
,
Ann-Lii Cheng,
Gerold Meinhardt,
Keiko Nakajima,
Yoriko De Sanctis,
Josep Llovet
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 